[{"path":"index.html","id":"overview","chapter":"1 Overview","heading":"1 Overview","text":"","code":""},{"path":"index.html","id":"outcomes-included","chapter":"1 Overview","heading":"1.1 Outcomes included","text":"","code":""},{"path":"index.html","id":"studies-currently-included","chapter":"1 Overview","heading":"1.2 Studies currently included","text":"109 currently included.","code":""},{"path":"index.html","id":"number-of-arms-per-timepoint","chapter":"1 Overview","heading":"1.3 Number of arms per timepoint","text":"","code":""},{"path":"mood-results.html","id":"mood-results","chapter":"2 Mood results","heading":"2 Mood results","text":"","code":""},{"path":"mood-results.html","id":"nma","chapter":"2 Mood results","heading":"2.1 NMA:","text":"Network meta-analysis results across conditions, classes, doses.","code":""},{"path":"mood-results.html","id":"antidepressant-at-1","chapter":"2 Mood results","heading":"2.1.1 antidepressant at 1","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-1","chapter":"2 Mood results","heading":"2.1.2 antidepressant at 1","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-2","chapter":"2 Mood results","heading":"2.1.3 antidepressant at 1","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-3","chapter":"2 Mood results","heading":"2.1.4 antidepressant at 1","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-4","chapter":"2 Mood results","heading":"2.1.5 antidepressant at 1","text":"","code":""},{"path":"mood-results.html","id":"conditions","chapter":"2 Mood results","heading":"2.2 Conditions","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-fibromyalgia","chapter":"2 Mood results","heading":"2.2.1 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-musculoskeletal","chapter":"2 Mood results","heading":"2.2.2 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-neuropathic","chapter":"2 Mood results","heading":"2.2.3 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-primary","chapter":"2 Mood results","heading":"2.2.4 antidepressant at 1 for primary","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-chest-pain","chapter":"2 Mood results","heading":"2.2.5 antidepressant at 1 for chest pain","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-fibromyalgia-1","chapter":"2 Mood results","heading":"2.2.6 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-musculoskeletal-1","chapter":"2 Mood results","heading":"2.2.7 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-primary-1","chapter":"2 Mood results","heading":"2.2.8 antidepressant at 1 for primary","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-fibromyalgia-2","chapter":"2 Mood results","heading":"2.2.9 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-musculoskeletal-2","chapter":"2 Mood results","heading":"2.2.10 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-neuropathic-1","chapter":"2 Mood results","heading":"2.2.11 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-fibromyalgia-3","chapter":"2 Mood results","heading":"2.2.12 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-musculoskeletal-3","chapter":"2 Mood results","heading":"2.2.13 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-neuropathic-2","chapter":"2 Mood results","heading":"2.2.14 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-unable-to-be-classified","chapter":"2 Mood results","heading":"2.2.15 antidepressant at 1 for unable to be classified","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-fibromyalgia-4","chapter":"2 Mood results","heading":"2.2.16 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"mood-results.html","id":"antidepressant-at-1-for-musculoskeletal-4","chapter":"2 Mood results","heading":"2.2.17 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"substantial-pain-results.html","id":"substantial-pain-results","chapter":"3 Substantial pain results","heading":"3 Substantial pain results","text":"","code":""},{"path":"substantial-pain-results.html","id":"nma-1","chapter":"3 Substantial pain results","heading":"3.1 NMA:","text":"Network meta-analysis results across conditions, classes, doses.","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-5","chapter":"3 Substantial pain results","heading":"3.1.1 antidepressant at 1","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-6","chapter":"3 Substantial pain results","heading":"3.1.2 antidepressant at 1","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-7","chapter":"3 Substantial pain results","heading":"3.1.3 antidepressant at 1","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-8","chapter":"3 Substantial pain results","heading":"3.1.4 antidepressant at 1","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-9","chapter":"3 Substantial pain results","heading":"3.1.5 antidepressant at 1","text":"","code":""},{"path":"substantial-pain-results.html","id":"conditions-1","chapter":"3 Substantial pain results","heading":"3.2 Conditions","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-fibromyalgia-5","chapter":"3 Substantial pain results","heading":"3.2.1 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-musculoskeletal-5","chapter":"3 Substantial pain results","heading":"3.2.2 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-neuropathic-3","chapter":"3 Substantial pain results","heading":"3.2.3 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-primary-2","chapter":"3 Substantial pain results","heading":"3.2.4 antidepressant at 1 for primary","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-chest-pain-1","chapter":"3 Substantial pain results","heading":"3.2.5 antidepressant at 1 for chest pain","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-fibromyalgia-6","chapter":"3 Substantial pain results","heading":"3.2.6 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-musculoskeletal-6","chapter":"3 Substantial pain results","heading":"3.2.7 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-primary-3","chapter":"3 Substantial pain results","heading":"3.2.8 antidepressant at 1 for primary","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-fibromyalgia-7","chapter":"3 Substantial pain results","heading":"3.2.9 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-musculoskeletal-7","chapter":"3 Substantial pain results","heading":"3.2.10 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-neuropathic-4","chapter":"3 Substantial pain results","heading":"3.2.11 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-fibromyalgia-8","chapter":"3 Substantial pain results","heading":"3.2.12 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-musculoskeletal-8","chapter":"3 Substantial pain results","heading":"3.2.13 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-neuropathic-5","chapter":"3 Substantial pain results","heading":"3.2.14 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-unable-to-be-classified-1","chapter":"3 Substantial pain results","heading":"3.2.15 antidepressant at 1 for unable to be classified","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-fibromyalgia-9","chapter":"3 Substantial pain results","heading":"3.2.16 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"substantial-pain-results.html","id":"antidepressant-at-1-for-musculoskeletal-9","chapter":"3 Substantial pain results","heading":"3.2.17 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"moderate-pain-intensity-results","chapter":"4 Moderate pain intensity results","heading":"4 Moderate pain intensity results","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"nma-2","chapter":"4 Moderate pain intensity results","heading":"4.1 NMA:","text":"Network meta-analysis results across conditions, classes, doses.","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-10","chapter":"4 Moderate pain intensity results","heading":"4.1.1 antidepressant at 1","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-11","chapter":"4 Moderate pain intensity results","heading":"4.1.2 antidepressant at 1","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-12","chapter":"4 Moderate pain intensity results","heading":"4.1.3 antidepressant at 1","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-13","chapter":"4 Moderate pain intensity results","heading":"4.1.4 antidepressant at 1","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-14","chapter":"4 Moderate pain intensity results","heading":"4.1.5 antidepressant at 1","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"conditions-2","chapter":"4 Moderate pain intensity results","heading":"4.2 Conditions","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-fibromyalgia-10","chapter":"4 Moderate pain intensity results","heading":"4.2.1 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-musculoskeletal-10","chapter":"4 Moderate pain intensity results","heading":"4.2.2 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-neuropathic-6","chapter":"4 Moderate pain intensity results","heading":"4.2.3 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-primary-4","chapter":"4 Moderate pain intensity results","heading":"4.2.4 antidepressant at 1 for primary","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-chest-pain-2","chapter":"4 Moderate pain intensity results","heading":"4.2.5 antidepressant at 1 for chest pain","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-fibromyalgia-11","chapter":"4 Moderate pain intensity results","heading":"4.2.6 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-musculoskeletal-11","chapter":"4 Moderate pain intensity results","heading":"4.2.7 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-primary-5","chapter":"4 Moderate pain intensity results","heading":"4.2.8 antidepressant at 1 for primary","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-fibromyalgia-12","chapter":"4 Moderate pain intensity results","heading":"4.2.9 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-musculoskeletal-12","chapter":"4 Moderate pain intensity results","heading":"4.2.10 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-neuropathic-7","chapter":"4 Moderate pain intensity results","heading":"4.2.11 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-fibromyalgia-13","chapter":"4 Moderate pain intensity results","heading":"4.2.12 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-musculoskeletal-13","chapter":"4 Moderate pain intensity results","heading":"4.2.13 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-neuropathic-8","chapter":"4 Moderate pain intensity results","heading":"4.2.14 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-unable-to-be-classified-2","chapter":"4 Moderate pain intensity results","heading":"4.2.15 antidepressant at 1 for unable to be classified","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-fibromyalgia-14","chapter":"4 Moderate pain intensity results","heading":"4.2.16 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"moderate-pain-intensity-results.html","id":"antidepressant-at-1-for-musculoskeletal-14","chapter":"4 Moderate pain intensity results","heading":"4.2.17 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"adverse-results.html","id":"adverse-results","chapter":"5 Adverse results","heading":"5 Adverse results","text":"","code":""},{"path":"adverse-results.html","id":"nma-3","chapter":"5 Adverse results","heading":"5.1 NMA:","text":"Network meta-analysis results across conditions, classes, doses.","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-15","chapter":"5 Adverse results","heading":"5.1.1 antidepressant at 1","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-16","chapter":"5 Adverse results","heading":"5.1.2 antidepressant at 1","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-17","chapter":"5 Adverse results","heading":"5.1.3 antidepressant at 1","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-18","chapter":"5 Adverse results","heading":"5.1.4 antidepressant at 1","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-19","chapter":"5 Adverse results","heading":"5.1.5 antidepressant at 1","text":"","code":""},{"path":"adverse-results.html","id":"conditions-3","chapter":"5 Adverse results","heading":"5.2 Conditions","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-fibromyalgia-15","chapter":"5 Adverse results","heading":"5.2.1 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-musculoskeletal-15","chapter":"5 Adverse results","heading":"5.2.2 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-neuropathic-9","chapter":"5 Adverse results","heading":"5.2.3 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-primary-6","chapter":"5 Adverse results","heading":"5.2.4 antidepressant at 1 for primary","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-chest-pain-3","chapter":"5 Adverse results","heading":"5.2.5 antidepressant at 1 for chest pain","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-fibromyalgia-16","chapter":"5 Adverse results","heading":"5.2.6 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-musculoskeletal-16","chapter":"5 Adverse results","heading":"5.2.7 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-primary-7","chapter":"5 Adverse results","heading":"5.2.8 antidepressant at 1 for primary","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-fibromyalgia-17","chapter":"5 Adverse results","heading":"5.2.9 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-musculoskeletal-17","chapter":"5 Adverse results","heading":"5.2.10 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-neuropathic-10","chapter":"5 Adverse results","heading":"5.2.11 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-fibromyalgia-18","chapter":"5 Adverse results","heading":"5.2.12 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-musculoskeletal-18","chapter":"5 Adverse results","heading":"5.2.13 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-neuropathic-11","chapter":"5 Adverse results","heading":"5.2.14 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-unable-to-be-classified-3","chapter":"5 Adverse results","heading":"5.2.15 antidepressant at 1 for unable to be classified","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-fibromyalgia-19","chapter":"5 Adverse results","heading":"5.2.16 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"adverse-results.html","id":"antidepressant-at-1-for-musculoskeletal-19","chapter":"5 Adverse results","heading":"5.2.17 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"quality-of-life-results.html","id":"quality-of-life-results","chapter":"6 Quality of life results","heading":"6 Quality of life results","text":"","code":""},{"path":"quality-of-life-results.html","id":"nma-4","chapter":"6 Quality of life results","heading":"6.1 NMA:","text":"Network meta-analysis results across conditions, classes, doses.","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-20","chapter":"6 Quality of life results","heading":"6.1.1 antidepressant at 1","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-21","chapter":"6 Quality of life results","heading":"6.1.2 antidepressant at 1","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-22","chapter":"6 Quality of life results","heading":"6.1.3 antidepressant at 1","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-23","chapter":"6 Quality of life results","heading":"6.1.4 antidepressant at 1","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-24","chapter":"6 Quality of life results","heading":"6.1.5 antidepressant at 1","text":"","code":""},{"path":"quality-of-life-results.html","id":"conditions-4","chapter":"6 Quality of life results","heading":"6.2 Conditions","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-fibromyalgia-20","chapter":"6 Quality of life results","heading":"6.2.1 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-musculoskeletal-20","chapter":"6 Quality of life results","heading":"6.2.2 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-neuropathic-12","chapter":"6 Quality of life results","heading":"6.2.3 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-primary-8","chapter":"6 Quality of life results","heading":"6.2.4 antidepressant at 1 for primary","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-chest-pain-4","chapter":"6 Quality of life results","heading":"6.2.5 antidepressant at 1 for chest pain","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-fibromyalgia-21","chapter":"6 Quality of life results","heading":"6.2.6 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-musculoskeletal-21","chapter":"6 Quality of life results","heading":"6.2.7 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-primary-9","chapter":"6 Quality of life results","heading":"6.2.8 antidepressant at 1 for primary","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-fibromyalgia-22","chapter":"6 Quality of life results","heading":"6.2.9 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-musculoskeletal-22","chapter":"6 Quality of life results","heading":"6.2.10 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-neuropathic-13","chapter":"6 Quality of life results","heading":"6.2.11 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-fibromyalgia-23","chapter":"6 Quality of life results","heading":"6.2.12 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-musculoskeletal-23","chapter":"6 Quality of life results","heading":"6.2.13 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-neuropathic-14","chapter":"6 Quality of life results","heading":"6.2.14 antidepressant at 1 for neuropathic","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-unable-to-be-classified-4","chapter":"6 Quality of life results","heading":"6.2.15 antidepressant at 1 for unable to be classified","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-fibromyalgia-24","chapter":"6 Quality of life results","heading":"6.2.16 antidepressant at 1 for fibromyalgia","text":"","code":""},{"path":"quality-of-life-results.html","id":"antidepressant-at-1-for-musculoskeletal-24","chapter":"6 Quality of life results","heading":"6.2.17 antidepressant at 1 for musculoskeletal","text":"","code":""},{"path":"pipeline.html","id":"pipeline","chapter":"7 Pipeline","heading":"7 Pipeline","text":"","code":""},{"path":"pipeline.html","id":"check-figure-sizing","chapter":"7 Pipeline","heading":"7.1 Check figure sizing","text":"","code":""},{"path":"pipeline.html","id":"joining-together-covidence-export-with-hollies-extractions","chapter":"7 Pipeline","heading":"7.2 Joining together Covidence export with Hollieâ€™s extractions","text":"","code":""},{"path":"pipeline.html","id":"labelling-protocol-for-covidence","chapter":"7 Pipeline","heading":"7.3 Labelling protocol for Covidence","text":"","code":""},{"path":"pipeline.html","id":"labels-not-specific-to-outcome","chapter":"7 Pipeline","heading":"7.3.1 Labels not specific to outcome","text":"","code":""},{"path":"pipeline.html","id":"condition","chapter":"7 Pipeline","heading":"7.3.1.1 Condition","text":"","code":""},{"path":"pipeline.html","id":"timepoint-or-change-score","chapter":"7 Pipeline","heading":"7.3.1.2 Timepoint or change score","text":"","code":""},{"path":"pipeline.html","id":"unmatched-timepoints","chapter":"7 Pipeline","heading":"7.3.1.2.1 Unmatched timepoints","text":"","code":""},{"path":"pipeline.html","id":"labels-specific-to-outcome","chapter":"7 Pipeline","heading":"7.3.2 Labels specific to outcome","text":"","code":""},{"path":"pipeline.html","id":"scales","chapter":"7 Pipeline","heading":"7.3.2.1 Scales","text":"","code":""},{"path":"pipeline.html","id":"checks","chapter":"7 Pipeline","heading":"7.4 Checks","text":"Check key points pipeline expected number joins meets.","code":""},{"path":"pipeline.html","id":"subgroups","chapter":"7 Pipeline","heading":"7.5 subgroups","text":"","code":""},{"path":"pipeline.html","id":"condition-1","chapter":"7 Pipeline","heading":"7.5.1 condition","text":"","code":""},{"path":"pipeline.html","id":"number-of-arms-per-study-per-timepoint","chapter":"7 Pipeline","heading":"7.6 Number of arms per study per timepoint","text":"","code":""}]
